This is the third in a series of nine National Wastewater Drug Monitoring Program reports to be publicly released by the Australian Criminal Intelligence Commission. The program aims to deliver on the recommendations of the Final Report of the National Ice Taskforce. It is the first program to provide leading-edge, coordinated national research and intelligence on illicit and licit drugs, with a specific focus on methylamphetamine and 13 other substances.
In 2016, the Australian Criminal Intelligence Commission received $3.6 million in funding under the Proceeds of Crime Act to deliver the National Wastewater Drug Monitoring Program over three years. The program provides a measure, rather than an estimate, of the use of a number of illicit drugs, as well as licit drugs including nicotine, alcohol and some pharmaceuticals. It gives us valuable insight into the trends and emerging issues of drug consumption across Australia and can identify new sources of threat.
The findings presented in the nine reports will give law enforcement, policy, regulatory and health agencies additional and more objective data on the use of methylamphetamine and other drugs. This data creates opportunities to shape the response to both the demand and the supply side of the illicit drug market, particularly in high-use areas.